Current Advances in the Pathogenesis of Varicose Veins

Journal of Surgical Research

Volumn 141, Issue 2, 2007, Pages 311-316

  Naoum, Joseph J ^a   Hunter, Glenn C ^b   Woodside, Kenneth J ^b   Chen, Changyi ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

matrix metalloproteinases; varicose veins; veins; venous remodeling

Indexed keywords

METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR;

EXTRACELLULAR MATRIX; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HYDROSTATIC PRESSURE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VARICOSIS; VASCULAR SMOOTH MUSCLE; VEIN VALVE;

EXTRACELLULAR MATRIX PROTEINS; HUMANS; MATRIX METALLOPROTEINASES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VARICOSE VEINS;

EID: 34447277603     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.08.007     Document Type: Review

References (42)

1. Adhikari A., Criqui M.H., Wool V., et al. The epidemiology of chronic venous diseases. Phlebology 15 (2000) 2
2. Ascher E., Jacob T., Hingorani A., et al. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins. J Vasc Surg 33 (2001) 1080
3. Badier-Commander C., Verbeuren T., Lebard C., et al. Increased TIMP/MMP ratio in varicose veins: A possible explanation for extracellular matrix accumulation. J Pathol 192 (2000) 105
4. Borden P., and Heller R.A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 7 (1997) 159
5. Evans C.J., Fowkes F.G., Hajivassiliou C.A., et al. Epidemiology of varicose veins. A review. Int Angiol 13 (1994) 263
6. Hirai M., Naiki K., and Nakayama R. Prevalence and risk factors of varicose veins in Japanese women. Angiology 41 (1990) 228
7. Carpentier P.H. Epidemiology and physiopathology of chronic venous leg diseases. Rev Prat 50 (2000) 1176
8. Hanemaaijer R., Koolwijk P., le Clercq L., et al. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 296 (1993) 803
9. Ishikawa Y., Asuwa N., Ishii T., et al. Collagen alteration in vascular remodeling by hemodynamic factors. Virchows Arch 437 (2000) 138
10. Kowalewski R., Sobolewski K., Wolanska M., et al. Matrix metalloproteinases in the vein wall. Int Angiol 23 (2004) 164
11. Lengyel I., and Acsady G. Histomorphological and pathobiochemical changes of varicose veins. A possible explanation of the development of varicosis. Acta Morphol Hung 38 (1990) 259
12. Danielsson G., Eklof B., Grandinetti A., et al. The influence of obesity on chronic venous disease. Vasc Endovascular Surg 36 (2002) 271
13. Hulens M., Vansant G., Claessens A.L., et al. Predictors of 6-minute walk test results in lean, obese and morbidly obese women. Scand J Med Sci Sports 13 (2003) 98
14. Iannuzzi A., Panico S., Ciardullo A.V., et al. Varicose veins of the lower limbs and venous capacitance in postmenopausal women: Relationship with obesity. J Vasc Surg 36 (2002) 965
15. Kockx M.M., Knaapen M.W., Bortier H.E., et al. Vascular remodeling in varicose veins. Angiology 49 (1998) 871
16. London N.J., and Nash R. ABC of arterial and venous disease. Varicose veins. BMJ 320 (2000) 1391
17. Michiels C., Arnould T., Thibaut-Vercruyssen R., et al. Perfused human saphenous veins for the study of the origin of varicose veins: Role of the endothelium and of hypoxia. Int Angiol 16 (1997) 134
18. Milroy C.M., Scott D.J., Beard J.D., et al. Histological appearances of the long saphenous vein. J Pathol 159 (1989) 311
19. Moneta G., and Hehler M. The lower extremity venous system: Anatomy and physiology of normal venous function and chronic venous insufficiency. Handbook of venous disorders (1986), Chapman & Hall, London
20. Rose S.S., and Ahmed A. Some thoughts on the aetiology of varicose veins. J Cardiovasc Surg (Torino) 27 (1986) 534
21. Psaila J.V., and Melhuish J. Viscoelastic properties and collagen content of the long saphenous vein in normal and varicose veins. Br J Surg 76 (1989) 37
22. Venturi M., Bonavina L., Annoni F., et al. Biochemical assay of collagen and elastin in the normal and varicose vein wall. J Surg Res 60 (1996) 245
23. Porto L.C., da Silveira P.R., de Carvalho J.J., et al. Connective tissue accumulation in the muscle layer in normal and varicose saphenous veins. Angiology 46 (1995) 243
24. Aunapuu M., and Arend A. Histopathological changes and expression of adhesion molecules and laminin in varicose veins. Vasa 34 (2005) 170
25. Nikolovska S., Pavlova L., Ancevski A., et al. The role of nitric oxide in the pathogenesis of venous ulcers. Acta Dermatovenerol Croat 13 (2005) 242
26. Michiels C., Bouaziz N., and Remacle J. Role of the endothelium and blood stasis in the development of varicose veins. Int Angiol 21 Suppl 1 (2002) 18
27. Agu O., Hamilton G., Baker D.M., et al. Endothelin receptors in the aetiology and pathophysiology of varicose veins. Eur J Vasc Endovasc Surg 23 (2002) 165
28. Schuller-Petrovic S., Siedler S., Kern T., et al. Imbalance between the endothelial cell-derived contracting factors prostacyclin and angiotensin II and nitric oxide/cyclic GMP in human primary varicosis. Br J Pharmacol 122 (1997) 772
29. Parra J.R., Cambria R.A., Hower C.D., et al. Tissue inhibitor of metalloproteinase-1 is increased in the saphenofemoral junction of patients with varices in the leg. J Vasc Surg 28 (1998) 669
30. Sansilvestri-Morel P., Nonotte I., Fournet-Bourguignon M.P., et al. Abnormal deposition of extracellular matrix proteins by cultured smooth muscle cells from human varicose veins. J Vasc Res 35 (1998) 115
31. Gillespie D.L., Patel A., Fileta B., et al. Varicose veins possess greater quantities of MMP-1 than normal veins and demonstrate regional variation in MMP-1 and MMP-13. J Surg Res 106 (2002) 233
32. Sansilvestri-Morel P., Rupin A., Jaisson S., et al. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 106 (2002) 479
33. Kosugi I., Urayama H., Kasashima F., et al. Matrix metalloproteinase-9 and urokinase-type plasminogen activator in varicose veins. Ann Vasc Surg 17 (2003) 234
34. Woodside K.J., Hu M., Burke A., et al. Morphologic characteristics of varicose veins: Possible role of metalloproteinases. J Vasc Surg 38 (2003) 162
35. Kakkos S.K., Zolota V.G., Peristeropoulou P., et al. Increased mast cell infiltration in familial varicose veins: Pathogenetic implications?. Int Angiol 22 (2003) 43
36. Ng M.Y., Andrew T., Spector T.D., et al. Linkage to the FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs. J Med Genet 42 (2005) 235
37. Kim D.I., Eo H.S., and Joh J.H. Identification of differentially expressed genes in primary varicose veins. J Surg Res 123 (2005) 222
38. Hollingsworth S.J., Powell G., Barker S.G., et al. Primary varicose veins: Altered transcription of VEGF and its receptors (KDR, flt-1, soluble flt-1) with sapheno-femoral junction incompetence. Eur J Vasc Endovasc Surg 27 (2004) 259
39. Shibuya M., and Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312 (2006) 549
40. Woodside K.J., Naoum J.J., Torry R.J., et al. Altered expression of vascular endothelial growth factor and its receptors in normal saphenous vein and in arterialized and stenotic vein grafts. Am J Surg 186 (2003) 561
41. Miao H.Q., and Klagsbrun M. Neuropilin is a mediator of angiogenesis. Cancer Metastasis Rev 19 (2000) 29
42. Oh H., Takagi H., Otani A., et al. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): A mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci USA 99 (2002) 383